glp 1 agonists mechanism of action GLP-1 Receptor as Treatments for Type 2 Diabetes GLP-1 & GIP Agonists |
Description
( Epub 20231228 )
Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine [press release]
p = 0.003)
doi: 10.1038/s41467-024-48780-6
